Table 2.
Cancer-Specific Treatment and Laboratory Values
Treatment | Value |
---|---|
Chemotherapy | 45 (56%)* |
Radiation therapy | 13 (16%) |
Average Gy | 3600 (2225–6450)† |
Treatment stage | |
First line | 32 (40%) |
Recurrence | 43 (54%) |
Pre-treatment | 5 (6%) |
Coagulopathy | |
Platelets | 90,000 (17,500–211,500) |
INR | 1.16 (1.08–1.40) |
PT | 12.9 (11.6–15.2) |
PTT | 30.0 (25.6–32.1) |
Transfusions | 41 (51%) |
PRBC | 3 (3.8%) |
Platelets | 38 (48%) |
FFP | 6 (7.5%) |
Cryoprecipitate | 1 (1.25%) |
30-day mortality | 29 (36%) |
Gy indicates Gray; INR, international normalized ratio; PT, prothrombin time; PTT, partial thromboplastin time; PRBC, packed red blood cells; and FFP, fresh frozen plasma.
Categorical variables are presented as N (%).
Continuous variables are presented as median (interquartile range).